 Connection
Olga Taraschenko to Female
This is a "connection" page, showing publications Olga Taraschenko has written about Female.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.349 |
|
|
|
-
Snehal I, Pulluru Y, Schissel M, Matyi J, Garlinghouse M, Ghonim HT, Phatak V, Taraschenko O. Impact of ictal spread on preoperative memory and language functions and postoperative seizure outcomes in drug-resistant epilepsy. Epilepsy Behav. 2025 Oct; 171:110497.
Score: 0.031
-
Wei D, Zhou DJ, Datta P, Taraschenko O. Recognizing encephalopathy in immune checkpoint inhibitor therapy: A single-center experience. Cancer Med. 2021 05; 10(9):2978-2986.
Score: 0.023
-
Datta P, Barrett W, Bentzinger M, Jasinski T, Jayagopal LA, Mahoney A, Pearon C, Swaminathan A, Vuppala A, Samson KK, Wang H, Taraschenko O. Ambulatory care for epilepsy via telemedicine during the COVID-19 pandemic. Epilepsy Behav. 2021 03; 116:107740.
Score: 0.023
-
Wei D, Garlinghouse M, Li W, Swingle N, Samson KK, Taraschenko O. Association between kinetic semiology of psychogenic nonepileptic spells and seizure type in dual disorder. Epilepsy Behav. 2021 01; 114(Pt A):107597.
Score: 0.023
-
Baang HY, Swingle N, Sajja K, Madhavan D, Shostrom VK, Taraschenko O. Towards Successes in the Management of Nonconvulsive Status Epilepticus: Tracing the Detection-to-Needle Trajectories. J Clin Neurophysiol. 2020 May; 37(3):253-258.
Score: 0.022
-
Wei D, Garlinghouse M, Li W, Swingle N, Samson KK, Taraschenko O. Utilization of brain imaging in evaluating patients with psychogenic nonepileptic spells. Epilepsy Behav. 2018 08; 85:177-182.
Score: 0.019
-
Arcot Jayagopal L, Samson KK, Taraschenko O. Driving with drug-resistant and controlled seizures from a patient's perspective: Assessment of attitudes and practices. Epilepsy Behav. 2018 04; 81:101-106.
Score: 0.019
-
Taraschenko OD, Nichter C, Pugh JA. Early Wallerian degeneration in a neonate with middle carotid artery stroke. Pediatr Neurol. 2015 Feb; 52(2):252-3.
Score: 0.015
-
Taraschenko OD, Powers KM. Neurotoxin-induced paralysis: a case of tick paralysis in a 2-year-old child. Pediatr Neurol. 2014 Jun; 50(6):605-7.
Score: 0.014
-
Taraschenko OD, Maisonneuve IM, Glick SD. Sex differences in high fat-induced obesity in rats: Effects of 18-methoxycoronaridine. Physiol Behav. 2011 Jun 01; 103(3-4):308-14.
Score: 0.012
-
Taraschenko OD, Maisonneuve IM, Glick SD. Resistance of male Sprague-Dawley rats to sucrose-induced obesity: effects of 18-methoxycoronaridine. Physiol Behav. 2011 Feb 01; 102(2):126-31.
Score: 0.011
-
Taraschenko OD, Maisonneuve IM, Glick SD. 18-Methoxycoronaridine, a potential anti-obesity agent, does not produce a conditioned taste aversion in rats. Pharmacol Biochem Behav. 2010 Sep; 96(3):247-50.
Score: 0.011
-
Taraschenko OD, Rubbinaccio HY, Maisonneuve IM, Glick SD. 18-methoxycoronaridine: a potential new treatment for obesity in rats? Psychopharmacology (Berl). 2008 Dec; 201(3):339-50.
Score: 0.010
-
Taraschenko OD, Shulan JM, Maisonneuve IM, Glick SD. 18-MC acts in the medial habenula and interpeduncular nucleus to attenuate dopamine sensitization to morphine in the nucleus accumbens. Synapse. 2007 Jul; 61(7):547-60.
Score: 0.009
-
Taraschenko OD, Rubbinaccio HY, Shulan JM, Glick SD, Maisonneuve IM. Morphine-induced changes in acetylcholine release in the interpeduncular nucleus and relationship to changes in motor behavior in rats. Neuropharmacology. 2007 Jul; 53(1):18-26.
Score: 0.009
-
Meletti S, Hanin A, Giovannini G, Bedin R, Burani M, Taruffi L, Orlandi N, Urbano T, D'Achille F, Malerba M, Basha MM, Eschbach K, Foreman B, Farias-Moeller R, Gaspard N, Gerard EE, Gofton T, Gopaul MT, Haider HA, Hantus ST, Herman S, Kang P, Day GS, Kandula P, Steriade C, Struck AF, Taraschenko O, Wainwright M, Yoo JY, Zhou DJ, Lattanzi S, Navarro V, Hirsch LJ. Acute Brain Injury in New-Onset Refractory Status Epilepticus and Etiology-Defined Status Epilepticus. JAMA Neurol. 2026 Jun 01; 83(6):563-572.
Score: 0.008
-
Eliashiv D, Rao VR, Jobst BC, Szaflarski JP, Rolston JD, Kaye LC, Ganguly TM, Bullinger K, Dugan PC, Burdette DE, Peters AY, Sheikh A, Haas KF, Nair DR, Mnatsakanyan L, Quraishi IH, Bensalem-Owen MK, Doherty MJ, Razavi B, Fisher TL, Skidmore C, Modur PN, Constantino TM, Salanova V, Cole AJ, Taraschenko O, Rivera-Cruz A, Wheless JW, Tandon N, Balabanov A, Aboumatar S, Fried I, Drees C, Shin HW, Jaisani Z, MacIver SE, Patra SE, Chang EF, Willie JT, Gwinn R, Stoub T, Stern JM, Crabtree T, Seale CG, McFadden SC, Norman JF, Johnson L, Morrell MJ. Postapproval Study for Brain-Responsive Neurostimulation for Drug-Resistant Focal Epilepsy: Three-Year Efficacy and Interim Safety Results. Neurology. 2026 May 12; 106(9):e214875.
Score: 0.008
-
Hanin A, Marois C, Guillemaud M, Chavez M, Cosme L, Hayatou Z, Besnard A, Goudard G, Masson V, Cousyn L, Cheval M, Denis JA, Alkouri R, Lamari F, Bisulli F, Eschbach K, Farias-Moeller R, Gaspard N, Gerard EE, Giovannini G, Gofton T, Gopaul MT, Kellogg M, Meletti S, Muccioli L, Pasini E, Taraschenko O, Torcida N, Wainwright MS, Yoo JY, Wong N, Bonnefont-Rousselot D, Demeret S, Hirsch LJ, Navarro V. Exploring pathways leading to drug-resistant epilepsy for patients with cryptogenic new onset refractory status epilepticus. Epilepsia. 2026 May; 67(5):2326-2346.
Score: 0.008
-
Gruen MD, Gopaul MT, Jimenez AD, Batra A, Blank LJ, Damien C, Day GS, Eschbach K, Gerard EE, Gofton TE, Hantus ST, Jette N, Jongeling A, Kang P, Kazazian K, Kellogg M, Kim M, Madani B, Morales M, Punia V, Steriade C, Struck A, Taraschenko O, Torcida N, Wainwright MS, Yoo JY, Gaspard N, Wong N, Hirsch LJ, Hanin A. Quality of life over time after new onset refractory status epilepticus. Epilepsia. 2026 01; 67(1):328-340.
Score: 0.008
-
Menousek J, Mordeson J, Dennis E, White ML, Taraschenko O, Abosch A. Enhanced Detection of Epileptogenic Zone Using Prisma 3T MRI in Patients with MRI-negative Focal Epilepsy. World Neurosurg. 2025 07; 199:124102.
Score: 0.008
-
Guillemaud M, Chavez M, Kobeissy F, Vezzani A, Jimenez AD, Basha MM, Batra A, Demeret S, Eka O, Eschbach K, Foreman B, Gaspard N, Gerard EE, Gofton TE, Haider HA, Hantus ST, Howe CL, Jongeling A, Kalkach-Aparicio M, Kandula P, Kazazian K, Kim M, Lai YC, Marois C, Mellor A, Mohamed W, Morales M, Pimentel CM, Ramirez AM, Steriade C, Struck AF, Taraschenko O, Torcida Sedano N, Wainwright MS, Yoo JY, Wang KKW, Navarro V, Hirsch LJ, Hanin A. Identification of Distinct Biological Groups of Patients With Cryptogenic NORSE via Inflammatory Profiling. Neurol Neuroimmunol Neuroinflamm. 2025 Jul; 12(4):e200403.
Score: 0.008
-
Taraschenko OD, Panchal V, Maisonneuve IM, Glick SD. Is antagonism of alpha3beta4 nicotinic receptors a strategy to reduce morphine dependence? Eur J Pharmacol. 2005 Apr 25; 513(3):207-18.
Score: 0.008
-
Xue C, Kowshik SS, Lteif D, Puducheri S, Jasodanand VH, Zhou OT, Walia AS, Guney OB, Zhang JD, Poésy S, Kaliaev A, Andreu-Arasa VC, Dwyer BC, Farris CW, Hao H, Kedar S, Mian AZ, Murman DL, O'Shea SA, Paul AB, Rohatgi S, Saint-Hilaire MH, Sartor EA, Setty BN, Small JE, Swaminathan A, Taraschenko O, Yuan J, Zhou Y, Zhu S, Karjadi C, Alvin Ang TF, Bargal SA, Plummer BA, Poston KL, Ahangaran M, Au R, Kolachalama VB. AI-based differential diagnosis of dementia etiologies on multimodal data. Nat Med. 2024 Oct; 30(10):2977-2989.
Score: 0.007
-
Hanin A, Jimenez AD, Gopaul M, Asbell H, Aydemir S, Basha MM, Batra A, Damien C, Day GS, Eka O, Eschbach K, Fatima S, Fields MC, Foreman B, Gerard EE, Gofton TE, Haider HA, Hantus ST, Hocker S, Jongeling A, Kalkach Aparicio M, Kandula P, Kang P, Kazazian K, Kellogg MA, Kim M, Lee JW, Marcuse LV, McGraw CM, Mohamed W, Orozco J, Pimentel CM, Punia V, Ramirez AM, Steriade C, Struck AF, Taraschenko O, Treister AK, Wainwright MS, Yoo JY, Zafar S, Zhou DJ, Zutshi D, Gaspard N, Hirsch LJ. Trends in management of patients with new-onset refractory status epilepticus (NORSE) from 2016 to 2023: An interim analysis. Epilepsia. 2024 Aug; 65(8):e148-e155.
Score: 0.007
-
Jimenez AD, Gopaul M, Asbell H, Aydemir S, Basha MM, Batra A, Damien C, Day GS, Eka O, Eschbach K, Fatima S, Fields MC, Foreman B, Gerard EE, Gofton TE, Haider HA, Hantus ST, Hocker S, Jongeling A, Kalkach Aparicio M, Kandula P, Kang P, Kazazian K, Kellogg MA, Kim M, Lee JW, Marcuse LV, McGraw CM, Mohamed W, Orozco J, Pimentel C, Punia V, Ramirez AM, Steriade C, Struck AF, Taraschenko O, Treister AK, Yoo JY, Zafar S, Zhou DJ, Zutshi D, Gaspard N, Hirsch LJ, Hanin A. Comparative analysis of patients with new onset refractory status epilepticus preceded by fever (febrile infection-related epilepsy syndrome) versus without prior fever: An interim analysis. Epilepsia. 2024 Jun; 65(6):e87-e96.
Score: 0.007
-
Jing J, Ge W, Struck AF, Fernandes MB, Hong S, An S, Fatima S, Herlopian A, Karakis I, Halford JJ, Ng MC, Johnson EL, Appavu BL, Sarkis RA, Osman G, Kaplan PW, Dhakar MB, Jayagopal LA, Sheikh Z, Taraschenko O, Schmitt S, Haider HA, Kim JA, Swisher CB, Gaspard N, Cervenka MC, Rodriguez Ruiz AA, Lee JW, Tabaeizadeh M, Gilmore EJ, Nordstrom K, Yoo JY, Holmes MG, Herman ST, Williams JA, Pathmanathan J, Nascimento FA, Fan Z, Nasiri S, Shafi MM, Cash SS, Hoch DB, Cole AJ, Rosenthal ES, Zafar SF, Sun J, Westover MB. Interrater Reliability of Expert Electroencephalographers Identifying Seizures and Rhythmic and Periodic Patterns in EEGs. Neurology. 2023 04 25; 100(17):e1737-e1749.
Score: 0.007
-
Karakis I, Lynam C, Taraschenko O, Staikova E, Drane DL. Concurrent EEG monitoring helps interpret neuropsychological testing results in patients with epilepsy. Epilepsy Behav. 2020 10; 111:107275.
Score: 0.006
-
McCallum SE, Taraschenko OD, Hathaway ER, Vincent MY, Glick SD. Effects of 18-methoxycoronaridine on ghrelin-induced increases in sucrose intake and accumbal dopamine overflow in female rats. Psychopharmacology (Berl). 2011 May; 215(2):247-56.
Score: 0.003
-
Hussain RJ, Taraschenko OD, Glick SD. Effects of nicotine, methamphetamine and cocaine on extracellular levels of acetylcholine in the interpeduncular nucleus of rats. Neurosci Lett. 2008 Aug 08; 440(3):270-4.
Score: 0.002
-
Panchal V, Taraschenko OD, Maisonneuve IM, Glick SD. Attenuation of morphine withdrawal signs by intracerebral administration of 18-methoxycoronaridine. Eur J Pharmacol. 2005 Nov 21; 525(1-3):98-104.
Score: 0.002
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|